Glynium Respicap
Prescription Required
Product introduction
Glynium Respicap is used to treat chronic obstructive pulmonary disease (COPD). This medicine helps the muscles around the lungs to stay relaxed and reduces symptoms like coughing, chest tightness and shortness of breath.
Glynium Respicap is used to protect against the unwanted effects of some muscle relaxing drugs, before a surgery to reduce saliva secretion and prevent or reduce slow heart beats during surgery
Glynium Respicap is used to protect against the unwanted effects of some muscle relaxing drugs, before a surgery to reduce saliva secretion and prevent or reduce slow heart beats during surgery
Uses of Glynium Respicap
Benefits of Glynium Respicap
In Treatment of Chronic obstructive pulmonary disease (COPD)
COPD (chronic obstructive pulmonary disease) is a group of lung diseases that cause breathing difficulties. COPD is caused by swelling of the airways that carry air in and out of the lungs. Glynium Respicap relaxes the muscles of these airways and widens it. This makes you breathe easy and gives relief from symptoms such as tightness in your chest, shortness of breath, wheezing and coughing. Avoid smoking and minimise your exposure to pollution, dust and fumes. Along with that, a little exercise each day can help you stay strong. Talk to your doctor about how much exercise is good for you.
Side effects of Glynium Respicap
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them
Common side effects of Glynium
- Sore throat
- Dryness in mouth
- Insomnia (difficulty in sleeping)
- Gastroenteritis
How to use Glynium Respicap
Use this medicine in the dose and duration as advised by your doctor. Check the label for directions before use.
How Glynium Respicap works
Glynium Respicap is an anticholinergic medication. It works by blocking the activity of a chemical messenger (acetylcholine) in the brain.
Safety advice
Alcohol
CONSULT YOUR DOCTOR
It is not known whether it is safe to consume alcohol with Glynium Respicap. Please consult your doctor.
Pregnancy
SAFE IF PRESCRIBED
Glynium Respicap is generally considered safe to use during pregnancy. Animal studies have shown low or no adverse effects to the developing baby; however, there are limited human studies.
Breast feeding
SAFE IF PRESCRIBED
Glynium Respicap is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.
Long-term use of Glynium Respicap might reduce milk production.
Long-term use of Glynium Respicap might reduce milk production.
Driving
No interaction found/established
Kidney
No interaction found/established
Liver
No interaction found/established
All substitutes
For informational purposes only. Consult a doctor before taking any medicines.
No substitutes found for this medicine
Quick tips
- Glynium Respicap is used for long-term management of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD).
- It does not work right away and should not be used to relieve sudden breathing problems.
- Take the first dose of this medicine under medical supervision as it may cause wheezing or tightening of the airways (bronchospasm) immediately after using.
- Avoid getting this medication into your eyes. It may cause eye pain/irritation, temporary blurred vision, and other vision changes.
- Inform your doctor if you have difficulty passing urine or have painful urination.
Fact Box
Chemical Class
Synthetic Quaternary Ammonium
Habit Forming
No
Therapeutic Class
RESPIRATORY
Action Class
Anticholinergic - Anaesthesia
Patient concerns
User feedback
Patients taking Glynium Respicap
Once A Day
94%
Twice A Day
6%
FAQs
Is Glynium Respicap a steroid?
No, Glynium Respicap is not a steroid. It belongs to a group of medicines called bronchodilators which are used to widen the airway of the respiratory tract. They also help to ease the breathing process in patients with breathing difficulties due to a certain type of lung disease like obstructive pulmonary disease (COPD).
How long should Glynium Respicap be taken?
The length of time depends on the severity and type of disease. Chronic obstructive pulmonary disease (COPD) is a long-term disease and you need to take this medicine every day as directed by the doctor to prevent attacks of breathing difficulty. It is to be taken regularly and not only when you have breathing problems or other symptoms of COPD.
Can Glynium Respicap inhalation cause difficulty in urination?
Inhalational Glynium Respicap can lead to retention of urine and difficulty of urination in old age individuals. It is more common in men with enlarged prostate or benign enlargement of prostate. This condition can cause difficulty in urination or painful urination or frequent urination or dribbling of urine. Inform the doctor if you already have any such problems before starting the treatment or if you experienced any problems during the treatment.
Can Glynium Respicap inhalation cause difficulty in vision?
Inhaling Glynium Respicap can lead to blurred vision and can even cause acute narrow-angle glaucoma. This medicine can cause pain in the eye or discomfort, nausea or vomiting, blurred vision, seeing halos or bright colors around lights, and red eyes. Immediately stop taking this medicine and contact the doctor if you encounter any of these symptoms.
Want to share the information?
Disclaimer:
Tata 1mg's sole intention is to ensure that its consumers get information that is expert-reviewed, accurate and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.References
- Mayo Clinic. Glycopyrrolate. [Accessed 28 Mar. 2019] (online) Available from:
- Drugs and Lactation Database (LactMed) [Internet]. Bethesda (MD): National Library of Medicine (US); 2006. Glycopyrrolate. [Updated 2018 Dec 3]. [Accessed 20 Feb. 2020] (online) Available from:
- Glycopyrrolate [Package Insert]. Auckland, New Zealand: Novartis New Zealand Limited; 2021. [Accessed 28 June 2023]. (online) Available from:
Marketer details
Name: Zydus Healthcare Limited
Address: Zydus Tower, CTS No- 460/6 of Village Pahadi, Off I. B. Patel Road, Goregaon (East), Mumbai-400 063
Country of origin: India
Lab tests offered by us
Related/Popular tests
39 people bought this recentlyMRP
₹418
Inclusive of all taxes
30.0 respicaps in 1 packet
SOLD OUT
Notify me